ArticleCancer gene therapy2004

hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.

Mitsuhiro Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.